Search

Search Constraints

You searched for: Author/Creator Tabak, Fehmi

Search Results

1. Long‐term follow‐up of patients treated with entecavir and peginterferon add‐on therapy for HBeAg‐positive chronic hepatitis B infection: ARES long‐term follow‐up. Issue 1 (27th September 2018)

3. Genome-wide Association Study Identifies Genetic Variants Associated With Early and Sustained Response to (Pegylated) Interferon in Chronic Hepatitis B Patients: The GIANT-B Study. (2nd February 2019)

4. IDDF2019-ABS-0168 Bone and renal safety are improved in chronic hbv patients 1 year after switching to tenofovir alafenamide (TAF) from tenofovir disoproxil fumarate (TDF). (June 2019)

5. 466Skin lesions in febrile neutropenic patients. (December 2014)

6. Ruxolitinib in addition to standard of care for the treatment of patients admitted to hospital with COVID-19 (RUXCOVID): a randomised, double-blind, placebo-controlled, phase 3 trial. (May 2022)

7. Low recurrence rate of hepatocellular carcinoma following ledipasvir and sofosbuvir treatment in a real‐world chronic hepatitis C patients cohort. Issue 6 (8th March 2019)

8. 1177Relapse in patients with chronic hepatitis B infection treated with oral antivirals (nucleotide / nucleoside), after treatment discontinuation. (December 2014)